Supply chains will become more local in the pharmaceutical industry, says healthcare CEO

Drug supply chains may become less global as a result of the pandemic, according to the chief executive of a pharmaceutical manufacturer. Martin Meeson, CEO of Fujifilm Diosynth Biotechnologies, told CNBC’s “Squawk Box Europe” that drug companies were working to make sure people had access to medicine. “I think […]

Click here to view original web page at www.cnbc.com